Skip to content

Clinical trials

Terminated Phase 3 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Status: Terminated Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20063
20073
20081
20091
20101
20111
20132
20143
20161
20181
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Sanofi2
Albert Einstein College of Medicine1
Assistance Publique - Hôpitaux de Paris1
CHIR-Net1
Corcept Therapeutics1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Gary Morrow1
Gilead Sciences1
Jiangsu HengRui Medicine Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms22
Adenocarcinoma3
Lung Neoplasms2
Thromboembolism2
Anorexia1
Bile Duct Neoplasms1
Body Weight1
Cachexia1
Carcinoma, Islet Cell1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.